Medtronic Inc: Company Report
710 Medtronic Parkway LC-480 Minneapolis MN 55432 http://www.medtronic.com/ - Phone: 763-5052692
- Fax: 763-5146272
- Industry : Medical Appliances & Equipment
- Employees : 37,665
- Exchange : NYSE
Medtronic, Inc. (Medtronic) is a global player in medical technology. The Company operates in seven segments that manufacture and sell device-based medical therapies: Cardiac Rhythm Disease Management, Spinal, CardioVascular, Neuromodulation, Diabetes, Surgical Technologies and Physio-Control. Through these seven segments, the Company develops, manufactures and markets its medical devices in more than 120 countries. Its primary products include those for cardiac rhythm disorders, cardiovascular disease, neurological disorders, spinal conditions and musculoskeletal trauma, urological and digestive disorders, diabetes, and ear, nose and throat conditions. The primary markets for products are the United States, Western Europe and Japan. In July 2008, it acquired Restore Medical, Inc. In November 2008, Medtronic acquired CryoCath Technologies Inc. In February 2009, it acquired Ablation Frontiers, Inc. and Ventor Technologies Ltd. In April 2009, Medtronic acquired CoreValve, Inc.
| Stock Activity |
| fyi |
Last Price |
42.36 |
|
52 Week High |
46.66 |
|
52 Week Low |
24.06 |
|
Volume |
NA |
|
Average Daily Volume (13wk) |
5.88 Mil |
| fyi |
50 Day Moving Average |
43.90 |
|
200 Day Moving Average |
37.80 |
|
Volatility (beta) |
0.77 |
| Stock Price History |
| | Change | Relative Strength |
| fyi |
Last 3 Months |
6.4% |
73 |
|
Last 6 Months |
14.1% |
68 |
| fyi |
Last 12 Months |
25.2% |
51 |
Historical charts
| Institutional Statistics |
|---|
| Analyst Consensus | Moderate Buy | | Institutional Ownership | 76.20% | More Analyst Ratings
Want to learn how to evaluate a stock? Walk through the steps using the Research Wizard. | advertisement
| Financials |
| | Last 12 Months | 5 Year Growth |
|
Sales |
15.1 Bil |
10.0% |
|
Income |
2.2 Bil |
2.1% |
| fyi |
Dividend Rate |
0.82 |
20.93% |
|
Dividend Yield |
1.96% |
1.00% |
More financials
| Fundamental Data |
|---|
| Debt/Equity Ratio | 0.55 | | Gross Margin | 75.70% | | Net Profit Margin | 14.34% | | Total Shares Outstanding | 1.1 Bil | | Market Capitalization | 46.79 Bil | | Earnings/Share | 1.94 |
More financial ratios
| Earnings Estimates
|
| Qtr(1/10) EPS Estimate |
0.76 |
| FY(4/10) EPS Estimate |
3.19 |
| Current P/E |
21.50 |
| FY(4/11) EPS Estimate |
3.51 |
| Forward P/E |
12.07 |
| Next Earnings Release:
N/A | | More analyst estimates
|